Huan-Ming Hsu

1.1k total citations
32 papers, 718 citations indexed

About

Huan-Ming Hsu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huan-Ming Hsu has authored 32 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Huan-Ming Hsu's work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers) and Epigenetics and DNA Methylation (4 papers). Huan-Ming Hsu is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers) and Epigenetics and DNA Methylation (4 papers). Huan-Ming Hsu collaborates with scholars based in Taiwan, United States and Italy. Huan-Ming Hsu's co-authors include Jyh‐Cherng Yu, Chen‐Yang Shen, Giu‐Cheng Hsu, Pei‐Ei Wu, Chun‐Wen Cheng, Chia‐Ni Hsiung, Hui‐Chun Wang, Guo‐Shiou Liao, Ming‐Feng Hou and Wen‐Cheng Chou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Huan-Ming Hsu

32 papers receiving 708 citations

Peers

Huan-Ming Hsu

ONCOL

GENET

PRM

Changchuan Pan China

Elizabeth V. Nguyen United States

Ayşe Özer Türkiye

Elisabetta Carico Italy

Matthew Camiolo United States

Anastasia Meshcheryakova Austria

Saioa Goñi Spain

S. Langbein Germany

Maria Grazia Vizioli Italy

Noora Andersson Finland

Changchuan Pan China

Huan-Ming Hsu

379 ×1.0

219 ×1.1

322 ×1.9

ONCOL

44 ×0.4

GENET

255 ×3.5

PRM

Citations per year, relative to Huan-Ming Hsu Huan-Ming Hsu (= 1×) peers Changchuan Pan

Countries citing papers authored by Huan-Ming Hsu

Since Specialization

Citations

This map shows the geographic impact of Huan-Ming Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan-Ming Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan-Ming Hsu more than expected).

Fields of papers citing papers by Huan-Ming Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan-Ming Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan-Ming Hsu. The network helps show where Huan-Ming Hsu may publish in the future.

Co-authorship network of co-authors of Huan-Ming Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Huan-Ming Hsu. A scholar is included among the top collaborators of Huan-Ming Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan-Ming Hsu. Huan-Ming Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Jyh‐Cherng, Huan-Ming Hsu, Chi-Hong Chu, et al.. (2023). The Risk of Breast Cancer between Western and Mediterranean Dietary Patterns. Nutrients. 15(9). 2057–2057. 19 indexed citations

Yu, Jyh‐Cherng, Huan-Ming Hsu, Chi-Hong Chu, et al.. (2022). The impact of frailty on breast cancer outcomes: evidence from analysis of the Nationwide Inpatient Sample, 2005-2018.. PubMed. 12(12). 5589–5598. 10 indexed citations

Chang, Yu-Tien, Wen‐Chiuan Tsai, Chia‐Chao Wu, et al.. (2022). A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 7 indexed citations

Lin, Kung‐Hung, Huan-Ming Hsu, Kuo‐Feng Hsu, et al.. (2021). Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study. PLoS ONE. 16(12). e0261258–e0261258. 2 indexed citations

Hsu, Huan-Ming, et al.. (2019). Subacute Carotid Stent Thrombosis Managed with Sandwich Stenting Technique: A Case Report. 44. 173–176. 1 indexed citations

Cheng, Kai‐Chun, Ruey‐Jen Lin, Jing‐Yan Cheng, et al.. (2019). FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding. EBioMedicine. 45. 25–38. 37 indexed citations

Fan, Tan‐Chi, Hui Ling Yeo, Huan-Ming Hsu, et al.. (2018). Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells. Cancer Letters. 434. 184–195. 37 indexed citations

Chou, Wen‐Cheng, Weiting Chen, Chia‐Ni Hsiung, et al.. (2017). B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers. Scientific Reports. 7(1). 44089–44089. 25 indexed citations

Liao, Guo‐Shiou, Yu‐Ching Chou, Mehra Golshan, et al.. (2015). Prognostic value of the lymph node ratio in breast cancer subtypes. The American Journal of Surgery. 210(4). 749–754. 20 indexed citations

10.

Liao, Guo‐Shiou, Yu‐Ching Chou, Huan-Ming Hsu, Ming‐Shen Dai, & Jyh‐Cherng Yu. (2014). The prognostic value of lymph node status among breast cancer subtypes. The American Journal of Surgery. 209(4). 717–724. 28 indexed citations

11.

Chu, Hou‐Wei, Chun‐Wen Cheng, Wen‐Cheng Chou, et al.. (2013). A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Human Molecular Genetics. 23(2). 355–367. 51 indexed citations

12.

Cheng, Chun‐Wen, Yu‐Fan Liu, Jyh‐Cherng Yu, et al.. (2012). Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast. Annals of Surgical Oncology. 19(13). 4129–4139. 30 indexed citations

13.

Lai, Hou‐Chuan, Huan-Ming Hsu, Chen‐Hwan Cherng, et al.. (2011). Interference of patent blue dye with pulse oximetry readings, methemoglobin measurements, and blue urine in sentinel lymph node mapping: A case report and review of the literature. Acta anaesthesiologica Taiwanica. 49(4). 162–164. 12 indexed citations

14.

Yu, Jyh‐Cherng, Chia‐Ni Hsiung, Huan-Ming Hsu, et al.. (2011). Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Research. 13(1). R13–R13. 29 indexed citations

15.

Hsu, Kuo‐Feng, et al.. (2011). Giant Gallbladder: Adenocarcinoma Complicated With Empyema. The Journal of Trauma: Injury, Infection, and Critical Care. 70(1). 261–261. 8 indexed citations

16.

Ding, Shian-ling, Jyh‐Cherng Yu, Shou‐Tung Chen, et al.. (2010). Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression. Clinical Cancer Research. 16(13). 3473–3484. 28 indexed citations

17.

Hsu, Kuo‐Feng, et al.. (2009). Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. International Journal of Infectious Diseases. 14(1). e77–e80. 10 indexed citations

18.

Yu, Jyh‐Cherng, Shian-ling Ding, Chih‐Hao Chang, et al.. (2009). Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis. 30(9). 1562–1570. 37 indexed citations

19.

Yu, Jyh‐Cherng, Huan-Ming Hsu, Shou‐Tung Chen, et al.. (2006). Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. Journal of Biomedical Science. 13(3). 419–432. 23 indexed citations

20.

Gao, Hong‐Wei, et al.. (2001). Carcinoid Tumor of the Spleen: Report of a Case. Surgery Today. 31(12). 1107–1109. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact